Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 10/20 | 0.51 |
| ▸ | PTPRC | P08575 | 1/20 | 0.50 |
| ▸ | PTPN13 | Q12923 | 1/20 | 0.50 |
| ▸ | MAOA | P21397 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.47 |
| ▸ | RAD52 | P43351 | 1/20 | 0.47 |
| ▸ | SMARCA2 | P51531 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14240229 | 1.00 | TERT (0.51) | TERTPTPRCPTPN13MAOAMEN1 | |
| SCHEMBL12110592 | 0.96 | TERT (0.52) | TERTPTPRCPTPN13MAOAMEN1 | |
| SCHEMBL14240029 | 0.91 | TERT (0.50) | TERTPTPRCPTPN13MAOAMEN1 | |
| SCHEMBL14239232 | 0.88 | TERT (0.53) | TERTPTPRCPTPN13MAOAMEN1 | |
| SCHEMBL14240478 | 0.88 | TERT (0.53) | TERTPTPRCPTPN13MAOAMEN1 | |
| SCHEMBL12110542 | 0.84 | TERT (0.54) | TERTPTPRCPTPN13MAOAMEN1 | |
| SCHEMBL14239233 | 0.83 | TERT (0.49) | TERTPTPRCPTPN13MAOAMEN1 | |
| SCHEMBL12110536 | 0.80 | TERT (0.50) | TERTPTPRCPTPN13MAOAMEN1 | |
| SCHEMBL1305106 | 0.79 | TERT (0.60) | TERTPTPRCPTPN13MAOAMEN1 | |
| SCHEMBL14240031 | 0.79 | PTPRC (0.58) | TERTPTPRCPTPN13MAOAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120316234-A1 | ANTHRAQUINONE -BASED COMPOUND, THE SYNTHESIS PROCESSES AND THE APPLICATION THEREOF | NATIONAL DEFENSE MEDICAL CENTER (TW) | 2012-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120316234-A1 | ANTHRAQUINONE -BASED COMPOUND, THE SYNTHESIS PROCESSES AND THE APPLICATION THEREOF | AAAS, QPCT, NQO2 | TERT 2376/4885PTPRC 4400/4885PTPN13 4825/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.